Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans

[1]  G. Pasterkamp,et al.  Single-cell T cell receptor sequencing of paired human atherosclerotic plaques and blood reveals autoimmune-like features of expanded effector T cells , 2023, Nature Cardiovascular Research.

[2]  M. Suarez‐Almazor,et al.  Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy , 2022, Nature Communications.

[3]  C. Lareau,et al.  Single-cell chromatin state analysis with Signac , 2021, Nature Methods.

[4]  Emma L Henderson,et al.  Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitors , 2021, JCI insight.

[5]  W. Jin,et al.  RORα is critical for mTORC1 activity in T cell-mediated colitis. , 2021, Cell reports.

[6]  Tian Wang,et al.  GdClean: removal of Gadolinium contamination in mass cytometry data , 2021, Bioinform..

[7]  C. Giannarelli,et al.  Immune cell profiling in atherosclerosis: role in research and precision medicine , 2021, Nature Reviews Cardiology.

[8]  M. Philip,et al.  CD8+ T cell differentiation and dysfunction in cancer , 2021, Nature Reviews Immunology.

[9]  Howard Y. Chang,et al.  Dynamic chromatin regulatory landscape of human CAR T cell exhaustion , 2021, Proceedings of the National Academy of Sciences.

[10]  Young Keun Kim,et al.  PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19 , 2020, Immunity.

[11]  Z. Fayad,et al.  Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis , 2020, JACC. CardioOncology.

[12]  G. Coukos,et al.  T-cell repertoire analysis and metrics of diversity and clonality. , 2020, Current opinion in biotechnology.

[13]  M. Fiorentino,et al.  New disappearance of complicated atheromatous plaques on rechallenge with PD-1/PD-L1 axis blockade in non-small cell lung cancer patient: follow up of an unexpected event , 2020, Therapeutic advances in medical oncology.

[14]  Hannah L Williams,et al.  Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy , 2020, Cell.

[15]  Loise M. Francisco,et al.  The PD-1 Pathway Regulates Development and Function of Memory CD8+ T Cells following Respiratory Viral Infection. , 2020, Cell reports.

[16]  D. Lambrechts,et al.  A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling , 2020, Cell Research.

[17]  K. Ley,et al.  T cell subsets and functions in atherosclerosis , 2020, Nature Reviews Cardiology.

[18]  Thomas D. Wu,et al.  Peripheral T cell expansion predicts tumour infiltration and clinical response , 2020, Nature.

[19]  T. Kishimoto,et al.  Arid5a, an RNA-Binding Protein in Immune Regulation: RNA Stability, Inflammation, and Autoimmunity. , 2020, Trends in immunology.

[20]  E. Lutgens,et al.  Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease , 2020, Journal for ImmunoTherapy of Cancer.

[21]  R. Rabadán,et al.  Tissue-Resident Memory T Cells Mediate Immune Homeostasis in the Human Pancreas through the PD-1/PD-L1 Pathway , 2019, Cell reports.

[22]  Fabian J Theis,et al.  Generalizing RNA velocity to transient cell states through dynamical modeling , 2019, Nature Biotechnology.

[23]  Nicolas F. Fernandez,et al.  Single-cell immune landscape of human atherosclerotic plaques , 2019, Nature Medicine.

[24]  Kamil Slowikowski,et al.  Fast, sensitive, and accurate integration of single cell data with Harmony , 2019, Nature Methods.

[25]  Aaron M. Newman,et al.  Single-cell transcriptional diversity is a hallmark of developmental potential , 2019, Science.

[26]  E. Wherry,et al.  CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer. , 2019, Annual review of immunology.

[27]  Howard Y. Chang,et al.  Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion , 2019, Nature Biotechnology.

[28]  I. Amit,et al.  Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma , 2019, Cell.

[29]  S. Zheng,et al.  Depletion of PD-1-positive cells ameliorates autoimmune disease , 2019, Nature Biomedical Engineering.

[30]  Andrew J. Hill,et al.  The single cell transcriptional landscape of mammalian organogenesis , 2019, Nature.

[31]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[32]  Andrew C. Adey,et al.  Cicero Predicts cis-Regulatory DNA Interactions from Single-Cell Chromatin Accessibility Data. , 2018, Molecular cell.

[33]  Erik Sundström,et al.  RNA velocity of single cells , 2018, Nature.

[34]  C. Klein,et al.  A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small cell lung cancer treated with PD-1 blockade , 2018, Nature Medicine.

[35]  Monika S. Kowalczyk,et al.  Induction and transcriptional regulation of the co-inhibitory gene module in T cells , 2018, Nature.

[36]  Xiaomin Song,et al.  The binding of an anti-PD-1 antibody to FcγRΙ has a profound impact on its biological functions , 2018, Cancer Immunology, Immunotherapy.

[37]  C. Benedict,et al.  Continuous activity of Foxo1 is required to prevent anergy and maintain the memory state of CD8+ T cells , 2018, The Journal of experimental medicine.

[38]  P. Libby,et al.  Taming Immune and Inflammatory Responses to Treat Atherosclerosis. , 2018, Journal of the American College of Cardiology.

[39]  Y. Kluger,et al.  Fast Interpolation-based t-SNE for Improved Visualization of Single-Cell RNA-Seq Data , 2017, Nature Methods.

[40]  A. Sharpe,et al.  The diverse functions of the PD1 inhibitory pathway , 2017, Nature Reviews Immunology.

[41]  Yufeng Shen,et al.  Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites. , 2017, Cell reports.

[42]  William J. Greenleaf,et al.  chromVAR: Inferring transcription factor-associated accessibility from single-cell epigenomic data , 2017, Nature Methods.

[43]  Shao-Cong Sun,et al.  NF-κB signaling in inflammation , 2017, Signal Transduction and Targeted Therapy.

[44]  J. Aerts,et al.  SCENIC: Single-cell regulatory network inference and clustering , 2017, Nature Methods.

[45]  Miles A. Miller,et al.  In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy , 2017, Science Translational Medicine.

[46]  Yuka Kanno,et al.  BACH2 regulates CD8+ T cell differentiation by controlling access of AP-1 factors to enhancers , 2016, Nature Immunology.

[47]  Hedi Peterson,et al.  g:Profiler—a web server for functional interpretation of gene lists (2016 update) , 2016, Nucleic Acids Res..

[48]  Hongbo Hu,et al.  Ubiquitin signaling in immune responses , 2016, Cell Research.

[49]  P. Linsley,et al.  MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data , 2015, Genome Biology.

[50]  A. Korman,et al.  FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis. , 2015, Cancer cell.

[51]  Paul A. Lyons,et al.  T cell exhaustion, costimulation and clinical outcome in autoimmunity and infection , 2015, Nature.

[52]  Eli R. Zunder,et al.  Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm , 2015, Nature Protocols.

[53]  M. Kaplan,et al.  Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation. , 2013, Immunity.

[54]  Sean C. Bendall,et al.  Normalization of mass cytometry data with bead standards , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[55]  Linda V. Sinclair,et al.  Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation , 2013, Nature Immunology.

[56]  J. Licht,et al.  Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. , 2013, Immunity.

[57]  S. Kaech,et al.  Transcriptional control of effector and memory CD8+ T cell differentiation , 2012, Nature Reviews Immunology.

[58]  U. Sampson,et al.  Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges , 2012, Current Atherosclerosis Reports.

[59]  B. Pamukcu,et al.  The nuclear factor--kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease. , 2011, Thrombosis research.

[60]  M. Matloubian,et al.  Expression of chemokine receptor CXCR3 on T cells affects the balance between effector and memory CD8 T-cell generation , 2011, Proceedings of the National Academy of Sciences.

[61]  M. Bruss,et al.  Phosphodiesterase 4B is essential for T(H)2-cell function and development of airway hyperresponsiveness in allergic asthma. , 2010, The Journal of allergy and clinical immunology.

[62]  Cheng Zhu,et al.  The kinetics of two dimensional TCR and pMHC interactions determine T cell responsiveness , 2010, Nature.

[63]  R. Welsh.  Blimp hovers over T cell immunity. , 2009, Immunity.

[64]  J. Weber,et al.  IL-21R on T Cells Is Critical for Sustained Functionality and Control of Chronic Viral Infection , 2009, Science.

[65]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[66]  Lieping Chen,et al.  Inhibitory B7-family molecules in the tumour microenvironment , 2008, Nature Reviews Immunology.

[67]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[68]  J David Spence,et al.  Technology Insight: ultrasound measurement of carotid plaque—patient management, genetic research, and therapy evaluation , 2006, Nature Clinical Practice Neurology.

[69]  Peter Libby,et al.  The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.

[70]  A. Tedgui,et al.  Cytokines in atherosclerosis: pathogenic and regulatory pathways. , 2006, Physiological reviews.

[71]  Tilman Brummer,et al.  Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1 , 2006, Nature Immunology.

[72]  D. Payan,et al.  A Novel E3 Ubiquitin Ligase TRAC-1 Positively Regulates T Cell Activation , 2005, The Journal of Immunology.

[73]  L. Santos‐Argumedo,et al.  CD38 is expressed selectively during the activation of a subset of mature T cells with reduced proliferation but improved potential to produce cytokines , 2005, Journal of leukocyte biology.

[74]  G. Zou,et al.  A modified poisson regression approach to prospective studies with binary data. , 2004, American journal of epidemiology.

[75]  M E J Newman,et al.  Community structure in social and biological networks , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[76]  G. Freeman,et al.  PD-L2 is a second ligand for PD-1 and inhibits T cell activation , 2001, Nature Immunology.

[77]  G. Freeman,et al.  Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation , 2000, The Journal of experimental medicine.

[78]  J. Larosa,et al.  Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. , 1999, JAMA.

[79]  W. Castelli.  Lipids, risk factors and ischaemic heart disease. , 1996, Atherosclerosis.

[80]  T. Honjo,et al.  Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. , 1996, International immunology.

[81]  T. Kohonen.  The self-organizing map , 1990, Neurocomputing.

[82]  J. Ravetch,et al.  Fcγ receptors as regulators of immune responses , 2008, Nature Reviews Immunology.